Mai Capital Management Atri Cure, Inc. Transaction History

Mai Capital Management

$13 Billion
Q1 2025

A detailed history of Mai Capital Management transactions in Atri Cure, Inc. stock. As of the latest transaction made, Mai Capital Management holds 10,380 shares of ATRC stock, worth $345,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,380

Previous 10,444 0.61%

Holding current value

$345,238

Previous $319,000 4.7%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$30.4 - $42.4 $1,945 - $2,713	-64 Reduced 0.61%	10,380 $334,000
Q4 2024 Feb 14, 2025	BUY	$27.02 - $38.2 $282,196 - $398,960	10,444 New	10,444 $319,000
Q3 2024 Nov 07, 2024	SELL	$20.34 - $29.5 $3,823 - $5,546	-188 Reduced 1.75%	10,580 $296,000
Q2 2024 Aug 12, 2024	SELL	$19.86 - $29.09 $15,530 - $22,748	-782 Reduced 6.77%	10,768 $245,000
Q1 2024 May 08, 2024	SELL	$28.21 - $37.78 $3,046 - $4,080	-108 Reduced 0.93%	11,550 $351,000
Q4 2023 Feb 09, 2024	SELL	$32.99 - $43.25 $4,123 - $5,406	-125 Reduced 1.06%	11,658 $416,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $22,410 - $31,462	-545 Reduced 4.42%	11,783 $516,000
Q2 2023 Aug 02, 2023	SELL	$40.44 - $49.6 $2,345 - $2,876	-58 Reduced 0.47%	12,328 $608,000
Q1 2023 May 10, 2023	SELL	$35.87 - $47.22 $36,408 - $47,928	-1,015 Reduced 7.57%	12,386 $513,000
Q4 2022 Feb 09, 2023	SELL	$33.48 - $47.45 $5,892 - $8,351	-176 Reduced 1.3%	13,401 $594,000
Q3 2022 Nov 15, 2022	SELL	$38.25 - $52.62 $38 - $52	-1 Reduced 0.01%	13,577 $531,000
Q1 2022 May 10, 2022	SELL	$57.43 - $71.39 $15,333 - $19,061	-267 Reduced 1.93%	13,578 $892,000
Q4 2021 Feb 11, 2022	SELL	$63.4 - $87.14 $17,244 - $23,702	-272 Reduced 1.93%	13,845 $963,000
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $18,705 - $22,804	-270 Reduced 1.88%	14,117 $982,000
Q2 2021 Jul 19, 2021	BUY	$64.13 - $80.18 $31,295 - $39,127	488 Added 3.51%	14,387 $1.14 Million
Q1 2021 May 10, 2021	SELL	$53.79 - $66.98 $4,841 - $6,028	-90 Reduced 0.64%	13,899 $911,000
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $11,508 - $19,164	-333 Reduced 2.33%	13,989 $779,000
Q3 2020 Oct 26, 2020	BUY	$38.36 - $46.91 $282,061 - $344,929	7,353 Added 105.51%	14,322 $571,000
Q2 2020 Jul 27, 2020	SELL	$31.78 - $51.19 $19,131 - $30,816	-602 Reduced 7.95%	6,969 $313,000
Q1 2020 Apr 16, 2020	SELL	$24.49 - $43.84 $42,343 - $75,799	-1,729 Reduced 18.59%	7,571 $254,000
Q4 2019 Feb 03, 2020	SELL	$24.06 - $32.51 $43,909 - $59,330	-1,825 Reduced 16.4%	9,300 $302,000
Q3 2019 Oct 29, 2019	SELL	$23.81 - $32.52 $7,571 - $10,341	-318 Reduced 2.78%	11,125 $277,000
Q2 2019 Aug 15, 2019	BUY	$26.85 - $30.74 $307,244 - $351,757	11,443 New	11,443 $341,000

Others Institutions Holding ATRC

# of Institutions

237

Shares Held

51.9M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.54B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Atri Cure, Inc. Transaction History